Proteotype Unveils Alchemi Platform for Enlighten Cancer Test
Proteotype Diagnostics unveiled Alchemi, a data and clinical workflow platform for its investigational Enlighten cancer blood test. The 15 month program starts September 1, 2026, with about €499,000 from the European Innovation Council.